Login to Your Account

X-Chem Racks Up the Milestones in Its Astrazeneca Partnership

By Catherine Shaffer
Staff Writer

Tuesday, September 24, 2013
X-Chem Inc., of Waltham, Mass., said it achieved several milestones in a licensing agreement with Astrazeneca plc, of London, established in May 2012. That deal garnered the company an up-front payment and research funding, as well as discovery and clinical development milestones.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription